Código QR

LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis

Abstract Many studies have reported the aberrant expression of lncRNAs and indicated their role in cancer progression and drug resistance across various cancers. In this study, we aimed to evaluate the effect of LINC00162 lncRNA on the chemosensitivity of thyroid cancer cells, both individually and...

Descrición completa

Gardado en:
Principais autores: Maryam Hejazi, Seyedeh Zahra Bahojb Mahdavi, Saba Abedimanesh, Ramin Heshmat, Bagher Larijani, Amir Ali Mokhtarzadeh, Gita Shafiee, Seyed Mohammad Tavangar
Formato: Artigo
Idioma:Inglês
Publicado: Nature Portfolio 2025-08-01
Series:Scientific Reports
Assuntos:
LINC00162
Thyroid Cancer
Sorafenib
Chemosensitivity
MAPK pathway
Apoptosis
Acceso en liña:https://doi.org/10.1038/s41598-025-12805-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares